Fluorescent In Situ Hybridization Probe Market Expansion Outlook: $2.23 Billion by 2029 Forecast

Global Fluorescent In Situ Hybridization Probe Market

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Is The Projected Market Size Of The Fluorescent In Situ Hybridization Probe Market By 2029?

The fluorescent in situ hybridization probe market has shown strong expansion in recent years. It is anticipated to increase from $1.55 billion in 2024 to $1.68 billion in 2025, growing at a compound annual growth rate (CAGR) of 7.8%. The historical growth of this market can be attributed to the rising adoption of cytogenetic analysis in prenatal screening, an increase in academic research focusing on chromosomal abnormalities, the expanding use of FISH in identifying microbes, a rise in government-funded genomics research efforts, and the enhanced capabilities of pathology laboratories.

The fluorescent in situ hybridization probe market is projected to experience robust expansion in the coming years. Its valuation is anticipated to reach $2.23 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 7.4%. This anticipated growth during the forecast period is fueled by several factors, including the increasing integration in research and diagnostic applications, a heightened need for multiplexed probe solutions for diagnosing rare diseases, an intensified emphasis on automation within cytogenetic testing procedures, the expanding utility of FISH in liquid biopsy, and its broadening application in plant and animal genomics research. Key trends anticipated during the same period encompass enhancements in probe signal amplification methods, the creation of nano-enabled FISH platforms, breakthroughs in automation-friendly FISH assay kits, sophisticated applications of machine learning in probe design, and the broader implementation of 3D FISH imaging.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27289&type=smp

Which Factors And Drivers Are Influencing The Fluorescent In Situ Hybridization Probe Market In 2025?

The fluorescent in situ hybridization probe market is anticipated to expand due to the growing acceptance of personalized medicine. Personalized medicine is a healthcare approach that leverages an individual’s genetic and lifestyle data to customize treatments and care plans. The rising uptake of personalized medicine stems from individuals favoring health technologies that provide real-time monitoring and treatment strategies tailored to their distinct biological makeup. Fluorescent in situ hybridization (FISH) probes play a crucial role in personalized medicine by accurately identifying genetic irregularities at the chromosomal level, thus informing customized treatment choices aligned with an individual’s specific genetic profile. As an illustration, in February 2023, the Personalized Medicine Coalition, a US-based professional membership organization, reported that in 2022, the approval of 12 new personalized medicines constituted roughly 34% of all newly approved therapies, demonstrating a significant rise compared to prior years. Consequently, the expanding adoption of personalized medicine is fueling the growth of the fluorescent in situ hybridization probe market.

How Is The Fluorescent In Situ Hybridization Probe Market Segmented?

The fluorescent in situ hybridization probe market covered in this report is segmented

1) By Type: Deoxyribonucleic Acid (DNA) Probes, Ribonucleic Acid (RNA) Probes, Multiplex Probes

2) By Target: Genes, Chromosomes, Other Targets

3) By Technology: Single-Color Fluorescence In Situ Hybridization (FISH), Multiplex Fluorescence In Situ Hybridization (FISH), Quantitative Fluorescence In Situ Hybridization (FISH), Others Technologies

4) By Application: Clinical Diagnostics, Research Applications, Agricultural Biotechnology, Pharmaceutical Research, Genetic Research

5) By End User: Hospitals And Clinics, Research Laboratories, Pharmaceutical Companies, Biotechnology Companies

Subsegments:

1) By Deoxyribonucleic Acid (DNA) Probes: Centromeric Probes, Telomeric Probes, Whole Chromosome Paint Probes, Locus-Specific Identifier (LSI) Probes, Comparative Genomic Hybridization (CGH) Probes, Gene Fusion Probes

2) By Ribonucleic Acid (RNA) Probes: mRNA Probes, Long Non-Coding RNA (lncRNA) Probes, MicroRNA (miRNA) Probes, Single-Molecule RNA FISH Probes (smFISH), Circular RNA (circRNA) Probes, Multiplexed Error-Robust FISH (MERFISH) Probes

3) By Multiplex Probes: Multicolor DNA FISH Probes, Multigene Expression Analysis Probes, High-Throughput Screening Probes, Multiplex smFISH Probes, Combinatorial Barcoded Probes, Simultaneous DNA/RNA Detection Probes

Which Market Trends Are Creating New Opportunities In The Fluorescent In Situ Hybridization Probe Industry?

Leading companies in the fluorescent in situ hybridization probe market are concentrating on forming strategic collaborations to gain access to new markets, technologies, or expertise that would otherwise be difficult or costly to acquire independently. A strategic collaboration signifies a planned partnership between two or more entities that work together by combining their strengths and resources to achieve shared long-term objectives and mutual benefits. For example, in April 2025, Empire Genomics, a US-based molecular diagnostics company, partnered with BioDot, a US-based provider of precision dispensing automation, to introduce the BDot Probe Line. The BDot Probe Line offers a unique solution by delivering FISH probes that are pre-optimized for automated systems, tackling a critical challenge in clinical cytogenetics and molecular pathology laboratories. These probes are engineered for direct use without requiring manual adjustments, ensuring seamless operation with the Biodot CellWriter S system. This innovation decreases the need for technician intervention, streamlines workflows, and shortens the turnaround time for results. The initial range of BDot Probe Panels supports FISH analysis for a broad spectrum of blood-related cancers, including MM, MDS, CML, AML, ALL, and other common hematologic conditions.

Which Leading Companies Dominate The Fluorescent In Situ Hybridization Probe Market Share?

Major companies operating in the fluorescent in situ hybridization probe market are Thermo Fisher Scientific Inc., Abbott Laboratories, Oxford Gene Technology IP Limited, Sigma-Aldrich Co. LLC, Agilent Technologies Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Leica Biosystems Nussloch GmbH, Biocare Medical LLC, Enzo Biochem Inc., LGC Biosearch Technologies, ZytoVision GmbH, Creative Biolabs Inc., Empire Genomics LLC, MetaSystems GmbH, Abnova Corporation, Mirus Bio LLC, Genemed Biotechnologies Inc., Molecular Instruments Inc., and Cytocell Technologies Limited.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/fluorescent-in-situ-hybridization-probe-global-market-report

How Does The Fluorescent In Situ Hybridization Probe Market Perform Across Key Geographic Regions?

North America was the largest region in the fluorescent in situ hybridization probe market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fluorescent in situ hybridization probe market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Fluorescent In Situ Hybridization Probe Market Report:

https://www.thebusinessresearchcompany.com/customise?id=27289&type=smp

Browse Through More Reports Similar to the Global Fluorescent In Situ Hybridization Probe Market 2025, By The Business Research Company

Insurance Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/insurance-global-market-report

Motor Insurance Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/motor-insurance-global-market-report

Home Insurance Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/home-insurance-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model